164 related articles for article (PubMed ID: 19838487)
1. Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients.
Silva EF; Bassichetto KC; Lewi DS
Arq Bras Cardiol; 2009 Aug; 93(2):113-8. PubMed ID: 19838487
[TBL] [Abstract][Full Text] [Related]
2. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
[TBL] [Abstract][Full Text] [Related]
5. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy.
Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U
Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505
[TBL] [Abstract][Full Text] [Related]
6. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
Koppel K; Bratt G; Eriksson M; Sandström E
Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
[TBL] [Abstract][Full Text] [Related]
7. Nutritional and clinical status, and dietary patterns of people living with HIV/AIDS in ambulatory care in Sao Paulo, Brazil.
Silva EF; Lewi DS; Vedovato GM; Garcia VR; Tenore SB; Bassichetto KC
Rev Bras Epidemiol; 2010 Dec; 13(4):677-88. PubMed ID: 21180856
[TBL] [Abstract][Full Text] [Related]
8. Causes of death among people living with AIDS in the pre- and post-HAART Eras in the city of São Paulo, Brazil.
Domingues CS; Waldman EA
PLoS One; 2014; 9(12):e114661. PubMed ID: 25500837
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome.
Ayodele OE; Akinboro AO; Akinyemi SO; Adepeju AA; Akinremi OA; Alao CA; Popoola AA
Metab Syndr Relat Disord; 2012 Oct; 10(5):373-9. PubMed ID: 22799758
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
[TBL] [Abstract][Full Text] [Related]
11. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects.
Bergersen BM; Sandvik L; Bruun JN; Tonstad S
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):625-30. PubMed ID: 15322938
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
Muhammad S; Sani MU; Okeahialam BN
Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Syndrome in HIV-patients in Antiretroviral Therapy.
Vargas-Pacherrez D; Cotrim HP; Pires L; Cunha V; Coelho V; Brites C; Daltro C
Curr HIV Res; 2020; 18(6):388-395. PubMed ID: 32516101
[TBL] [Abstract][Full Text] [Related]
14. Lipid profile in HIV/AIDS patients in Nigeria.
Adewole OO; Eze S; Betiku Y; Anteyi E; Wada I; Ajuwon Z; Erhabor G
Afr Health Sci; 2010 Jun; 10(2):144-9. PubMed ID: 21326966
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.
Manuthu EM; Joshi MD; Lule GN; Karari E
East Afr Med J; 2008 Jan; 85(1):10-7. PubMed ID: 18543521
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.
Cahn P; Leite O; Rosales A; Cabello R; Alvarez CA; Seas C; Carcamo C; Cure-Bolt N; L'Italien GP; Mantilla P; Deibis L; Zala C; Suffert T
Braz J Infect Dis; 2010; 14(2):158-66. PubMed ID: 20563442
[TBL] [Abstract][Full Text] [Related]
17. Haptoglobin phenotypes with weak antioxidant capacity increase risk factors of cardiovascular disease in Ghanaian HIV-infected patients on highly active antiretroviral therapy.
Tagoe EA; Tagoe INA; Kuleape JA; Puplampu P; Amanquah S; Asare-Anane H; Quaye O
Trop Med Int Health; 2019 Jun; 24(6):766-774. PubMed ID: 30851231
[TBL] [Abstract][Full Text] [Related]
18. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
Achila OO; Abrhaley F; Kesete Y; Tesfaldet F; Alazar F; Fisshaye L; Gebremeskel L; Mehari R; Andemichael D
PLoS One; 2022; 17(7):e0270838. PubMed ID: 35776747
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.
Wu PY; Hung CC; Liu WC; Hsieh CY; Sun HY; Lu CL; Wu H; Chien KL
J Antimicrob Chemother; 2012 Apr; 67(4):1001-9. PubMed ID: 22232517
[TBL] [Abstract][Full Text] [Related]
20. Impact of HIV infection and HAART on serum lipids in men.
Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
